Category Archives: MTN 007

  1. AIDS 2012: Meet Rig

    via BETA, by San Fransisco AIDS Foundation Rig Rush of the Black AIDS Institute is the “mobilization coordinator of everything gay black male,” an advocate of better and earlier sex education for youth—and a volunteer in a rectal microbicide trial. Throughout the MTN-007 study, which looked at the safety and acceptability of a gel containing the HIV Read More >>

    AIDS 2012, gay black men, HIV, hiv prevention, IRMA, Meet a Friendly Rectal Microbicide Advocate, MTN 007, rectal microbicide, Tenofovir, testing
  2. AIDSmeds: Rectal Microbicide Shows Better Safety in Laboratory Study

    via AIDSmeds Laboratory testing of a modified version of the Viread (tenofovir) microbicide gel provides further evidence that it may be safe for rectal use, according to a paper published online ahead of print by the Journal of Antimicrobial Chemotherapy. The encouraging results contribute to a better understanding of the gel’s tolerability, already evident in preliminary findings Read More >>

    Microbicide Trials Network, MTN 007, MTN 017, rectal microbicide, research, Tenofovir, Truvada
  3. Reformulation of Tenofovir Vaginal Gel Safe for Rectal Use

    via Eurekalert.org A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In laboratory tests of rectal tissue, researchers from the Microbicide Trials Network (MTN) found that the reformulated gel Read More >>

    2012, CROI, Microbicide Trials Network, Microbicides, MTN, MTN 007, rectal microbicide, Tenofovir, vaginal microbicide
  4. CROI Reports Rectal Tenofovir Trial Results

    via AidsMap.com, by Gus Cairns A gel containing 1% tenofovir formulated specifically for rectal use was much better tolerated than gels used in previous rectal microbicide trials when used in a safety study in 65 HIV-negative men and women, the 19th Conference on Retroviruses and Opportunistic Infections (CROI) heard yesterday. The gel was also compared with other Read More >>

    clinical trials, CROI, Microbicide Trials Network, Microbicides, MTN 007, rectal microbicide, Tenofovir
  5. Join IRMA for an Upcoming FREE Global Teleconference on the Latest in Rectal Microbicide Research

    Rectal Microbicide Research Update – MTN 007 and MTN 017 There are exciting new developments in the rectal microbicide field. Please join IRMA and AVAC for a FREE global teleconference Thursday, March 15, 10am eastern, featuring Drs. Ian McGowan and Ross Cranston of the Microbicide Trials Network (MTN). Ian (co-principal investigator of the MTN) will share results Read More >>

    Dr. Ian McGowan, Dr. Ross Cranston, IRMA, MTN, MTN 007, MTN 017, rectal microbicide, teleconference
  6. International Rectal Microbicide Advocates cheers launch of world’s third rectal microbicide trial

    Calls for more funding to strengthen field This brings us another step closer to the development of safe and effective rectal microbicides for use during anal intercourse. The world’s third rectal microbicide trial launched in Pittsburgh, Pennsylvania today, with sites preparing to open in Boston, Massachusetts, and Birmingham, Alabama soon. Scientists will test the rectal safety and Read More >>

    Africa, anal intercourse, IRMA, IRMA Nigeria, Kadiri Audu, MTN, MTN 007, Pittsburgh, rectal microbicide, Tenofovir